Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PZ HTL SA
GLOBETECH PUBLISHING LLC

Bioprinting 3D Technology Mimics Liver to Detoxify Blood

By BiotechDaily International staff writers
Posted on 27 May 2014
Image: Nanoengineers have developed a 3D printed device inspired by the liver to remove dangerous toxins from the blood. The device, which is designed to be used outside the body like dialysis, uses nanoparticles to trap pore-forming toxins that can damage cellular membranes and are a key factor in illnesses that result from animal bites and stings, and bacterial infections (Photo courtesy of UCSD – the University of California, San Diego).
Image: Nanoengineers have developed a 3D printed device inspired by the liver to remove dangerous toxins from the blood. The device, which is designed to be used outside the body like dialysis, uses nanoparticles to trap pore-forming toxins that can damage cellular membranes and are a key factor in illnesses that result from animal bites and stings, and bacterial infections (Photo courtesy of UCSD – the University of California, San Diego).
Nanoengineers have developed a three-dimensional (3D)-printed device to act like the liver to remove harmful toxins from the blood. The device, which is designed to be used outside the body, similar to dialysis, utilizes nanoparticles to trap pore-forming toxins that can injure cellular membranes and are a major factor in disorders that result from stings, animal bites, and bacterial infections.

The study’s findings were published May 8, 2014, in the journal Nature Communications. Nanoparticles have already been shown to be effective at neutralizing pore-forming toxins in the blood, but if those nanoparticles cannot be effectively digested, they can accumulate in the liver creating a risk of secondary poisoning, particularly among patients who are already at risk of liver failure. To resolve this problem, a team of investigators, led by University of California, San Diego’s (UCSD; USA) nanoengineering Prof. Shaochen Chen devised a 3D-printed hydrogel matrix to hold nanoparticles, forming a device that mimics the function of the liver by sensing, attracting, and capturing toxins channeled from the blood.

The device, which is in the proof-of-concept phase, replicates the structure of the liver but has a larger surface area designed to effectively lure and trap toxins within the device. In an in vitro study, the device totally neutralized pore-forming toxins. “One unique feature of this device is that it turns red when the toxins are captured,” said the co-first author, Xin Qu, who is a postdoctoral researcher working in Prof. Chen’s laboratory. “The concept of using 3D printing to encapsulate functional nanoparticles in a biocompatible hydrogel is novel,” said Prof. Chen. “This will inspire many new designs for detoxification techniques since 3D printing allows user-specific or site-specific manufacturing of highly functional products.”

Prof. Chen’s lab has already validated the ability to print complex 3D microstructures, such as blood vessels, in only seconds out of soft biocompatible hydrogels that contain living cells.

Related Links:

University of California, San Diego



comments powered by Disqus

Channels

Genomics/Proteomics

view channel

New Program Encourages Wide Distribution of Genomic Data

A new data sharing program allows genomics researchers and practitioners to analyze, visualize, and share raw sequence data for individual patients or across populations straight from a local browser. The sequencing revolution is providing the raw data required to identify the genetic variants underlying rare diseases... Read more

Drug Discovery

view channel
Image: The nano-cocoon drug delivery system is biocompatible, specifically targets cancer cells, can carry a large drug load, and releases the drugs very quickly once inside the cancer cell. Ligands on the surface of the \"cocoon\" trick cancer cells into consuming it. Enzymes (the “worms\" in this image) inside the cocoon are unleashed once inside the cell, destroying the cocoon and releasing anticancer drugs into the cell (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Novel Anticancer Drug Delivery System Utilizes DNA-Based Nanocapsules

A novel DNA-based drug delivery system minimizes damage to normal tissues by utilizing the acidic microenvironment inside cancer cells to trigger the directed release of the anticancer drug doxorubicin (DOX).... Read more

Business

view channel

Interest in Commercial Applications for Proteomics Continues to Grow

Increasing interest in the field of proteomics has led to a series of agreements between private proteomic companies and academic institutions as well as deals between pharmaceutical companies and novel proteomics innovator biotech companies. Proteomics is the study of the structure and function of proteins.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.